General Information of Drug (ID: DMIUX3D)

Drug Name
Methyl aminolevulinate Drug Info
Synonyms
Metvix; Aminolevulinic acid methyl ester; Methyl 5-aminolevulinate; Methyl delta-aminolevulinate; Methyl5-amino-4-oxopentanoate; Levulinic acid, 5-amino-, methyl ester; Pentanoic acid, 5-amino-4-oxo-, methyl ester; 5-Aminolevulinic acid methyl ester
Indication
Disease Entry ICD 11 Status REF
Acne vulgaris ED80 Approved [1]
Therapeutic Class
Anticancer Agents
Cross-matching ID
PubChem CID
157922
ChEBI ID
CHEMBL724125
CAS Number
CAS 33320-16-0
TTD Drug ID
DMIUX3D

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Investigative Drug(s)
Drug(s) Targeting Ferrochelatase (FECH)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cholic Acid DM7OKQV Cholelithiasis DC11 Approved [3]
N-Methylmesoporphyrin Containing Copper DMKZL5H Discovery agent N.A. Investigative [3]
Lead acetate DML0GZ2 Discovery agent N.A. Investigative [4]
N-Methylmesoporphyrin DM4FMZP Discovery agent N.A. Investigative [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Ferrochelatase (FECH) TTQ6VF4 HEMH_HUMAN Activator [2]

References

1 FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 021415.
2 Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo. Clin Cancer Res. 2009 May 15;15(10):3333-43.
3 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
4 Ferrochelatase, a novel target for photodynamic therapy of cancer. Oncol Rep. 1999 Nov-Dec;6(6):1439-42.